Ropinirole hydrochloride for amyotrophic lateral sclerosis: a single-center, randomized, double-blind, placebo-controlled phase 1/2a feasibility trial
Description
These data are the deposited supplemental information for the article entitled "Ropinirole hydrochloride for amyotrophic lateral sclerosis: a single-center, randomized, double-blind, placebo-controlled phase 1/2a feasibility trial" by Morimoto and Takahashi et al. in Cell Stem Cell.
Files
Institutions
Categories
Funding
Japan Agency for Medical Research and Development
JP22bm0804003, JP20ek0109395, JP20ek0109329, JP22ek0109493, JP22wm0425009
Japan Society for the Promotion of Science
JP22K15736, JP21H05273, JP22K07500, JP20H00485, JP21H05273, JP16H06277
K Pharma, Inc.
Uehara Memorial Foundation
YUKIHIKO MIYATA MEMORIAL TRUST FOR ALS RESEARCH
Okasan-Kato Foundation Research Grant
Yoshio Koide Grant, Japan ALS Association
Intramural Research Grant for Neurological Psychiatric Disorders from National Centre of Neurology and Psychiatry (NCNP)